To clarify I am not anti-vaxx. However, there are no long term studies of mRNA vaccines in humans.
this paper www.mdpi.com/2076-393X/7/2/37/htm makesme slightly wearing of getting an mRNA vaccine without long term trials being completed. However, the UK has bought different vaccines, but we dont know how they will be distributed etc.
So, am i being reasonable to say that we should be able to choose [and pay if needed] for a vaccine that we want if they are all proven effective, especially for me as I am low risk [only 10 females aged 20-24 have died from covid since Feb], I dont see the need for myself to be subjected to brand new vaccine technology.
www.bbc.co.uk/news/health-53772650
different vaccines the UK has bought:
Adenovirus vaccines: 100 million doses Oxford University/AstraZeneca; 30 million doses Janssen
-ebola vaccine
mRNA vaccines: 30 million doses BioNTech/Pfizer
-never done before
Inactivated whole virus vaccines: 60 million doses Valneva
[such as polio, hepatitis and rabies vaccines]
Protein adjuvant vaccines: 60 million doses GSK/Sanofi; 60 million doses Novavax
[such as hepititis B vaccine, which is 'composed of the hepatitis B virus surface antigen (HBsAg), a protein produced by hepatitis B virus'. An adjuvant is an ingredient used in some vaccines that helps create a stronger immune response in people receiving the vaccine, adjuvants are already used in vaccines and are benefical for older ppl, or others who may have weaker responses to vaccines].